Genetec Technology Berhad Management
Management criteria checks 2/4
Genetec Technology Berhad's CEO is Kem Chin, appointed in Oct 1997, has a tenure of 27.17 years. total yearly compensation is MYR994.42K, comprised of 105.1% salary and -5.1% bonuses, including company stock and options. directly owns 7.64% of the company’s shares, worth MYR74.35M. The average tenure of the management team and the board of directors is 15.2 years and 2.8 years respectively.
Key information
Kem Chin
Chief executive officer
RM 994.4k
Total compensation
| CEO salary percentage | 105.1% |
| CEO tenure | 27.2yrs |
| CEO ownership | 7.6% |
| Management average tenure | 15.2yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Genetec Technology Berhad (KLSE:GENETEC) Shares Fly 25% But Investors Aren't Buying For Growth
Dec 08
Analysts Just Shaved Their Genetec Technology Berhad (KLSE:GENETEC) Forecasts Dramatically
Dec 03Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Nov 28Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 23Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Sep 22Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be
Aug 27Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%
Aug 19Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Aug 06Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable
Feb 26Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement
Jan 15Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders
Sep 22Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?
Feb 08Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency
Dec 28Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?
Nov 17Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital
Aug 16Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet
Jul 21Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 30Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price
Apr 28Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)
Mar 23Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Feb 24Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Nov 04The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon
Sep 08Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders
Aug 05Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Jul 30Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?
Jun 11How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?
Feb 10Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters
Jan 14Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Dec 24
Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Dec 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | RM 994k | RM 1m | RM 69m |
| Mar 31 2024 | n/a | n/a | RM 76m |
| Dec 31 2023 | n/a | n/a | RM 69m |
| Sep 30 2023 | n/a | n/a | RM 59m |
| Jun 30 2023 | n/a | n/a | RM 66m |
| Mar 31 2023 | RM 965k | RM 829k | RM 50m |
| Dec 31 2022 | n/a | n/a | RM 70m |
| Sep 30 2022 | n/a | n/a | RM 75m |
| Jun 30 2022 | n/a | n/a | RM 67m |
| Mar 31 2022 | RM 952k | RM 827k | RM 56m |
| Dec 31 2021 | n/a | n/a | RM 37m |
| Sep 30 2021 | n/a | n/a | RM 20m |
| Jun 30 2021 | n/a | n/a | RM 6m |
| Mar 31 2021 | RM 947k | RM 821k | -RM 4m |
| Dec 31 2020 | n/a | n/a | -RM 6m |
| Sep 30 2020 | n/a | n/a | RM 1m |
| Jun 30 2020 | n/a | n/a | -RM 1m |
| Mar 31 2020 | RM 1m | RM 840k | -RM 166k |
| Dec 31 2019 | n/a | n/a | RM 4m |
| Sep 30 2019 | n/a | n/a | RM 469k |
| Jun 30 2019 | n/a | n/a | RM 981k |
| Mar 31 2019 | RM 1m | RM 851k | RM 6m |
| Dec 31 2018 | n/a | n/a | RM 10m |
| Sep 30 2018 | n/a | n/a | RM 8m |
| Jun 30 2018 | n/a | n/a | RM 6m |
| Mar 31 2018 | RM 1m | RM 865k | RM 4m |
Compensation vs Market: Kem's total compensation ($USD221.46K) is above average for companies of similar size in the MY market ($USD125.42K).
Compensation vs Earnings: Kem's compensation has been consistent with company performance over the past year.
CEO
Kem Chin (54 yo)
27.2yrs
Tenure
RM 994,416
Compensation
Mr. Kem Weng Chin serves as the Managing Director of Genetec Technology Berhad since October 27, 1997 and serves as its Executive Director. Mr. Chin joined Applied Magnetics Malaysia Sdn Bhd (Disc Drive Re...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 27.2yrs | RM 994.42k | 7.64% MYR 74.4m | |
| COO & Executive Director | 15.2yrs | RM 849.14k | 1.49% MYR 14.5m | |
| Chief Financial Officer | 15.2yrs | no data | 1.64% MYR 16.0m | |
| Company Secretary | 14.2yrs | no data | no data |
15.2yrs
Average Tenure
53yo
Average Age
Experienced Management: GENETEC's management team is seasoned and experienced (15.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | no data | RM 994.42k | 7.64% MYR 74.4m | |
| COO & Executive Director | 6.2yrs | RM 849.14k | 1.49% MYR 14.5m | |
| Independent Non-Executive Director | 4.3yrs | RM 142.00k | 0.10% MYR 992.0k | |
| Independent Non-Executive Director | 2.8yrs | RM 90.00k | 0.013% MYR 124.0k | |
| Independent Non-Executive Director | 1.2yrs | RM 54.00k | no data | |
| Independent Non-Executive Chairman | 1.6yrs | RM 156.00k | 0.26% MYR 2.5m |
2.8yrs
Average Tenure
54yo
Average Age
Experienced Board: GENETEC's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 19:17 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genetec Technology Berhad is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shafiq Kadir | CGS International |
| null null | CLSA |
| Ee Yap | CLSA |